10 Non-Prescription Weight Loss Injections to Consider Today

Introduction

Feeling overwhelmed by the weight loss options available today is a common struggle for many. Non-prescription weight loss injections have emerged as a compelling alternative for those seeking effective solutions without the need for a prescription. In this article, we’ll explore ten innovative non-prescription weight loss injections that might just be what you’re looking for, examining their benefits, effectiveness, and how they can be tailored to individual needs. But with so many choices, it’s important to find the injection that fits your unique weight loss journey.

Innovative Medicine: Personalized Weight Loss Injections for Holistic Health

Finding the right path to a healthier body can feel overwhelming, but at Innovative Medicine, we’re here to guide you every step of the way. We prioritize individualized care in our programs, seamlessly integrating natural and conventional medical methods. Our treatment plan includes non prescription weight loss injections that are tailored to meet your unique needs, ensuring alignment with your distinct health objectives. This approach not only helps reduce excess body mass but also boosts your overall well-being, making it a crucial element of our practice. We’re committed to providing compassionate care that truly prioritizes your needs.

Many struggle to find effective weight loss solutions that truly cater to their unique needs. Recent statistics show that personalized programs for reducing body mass can significantly enhance results. Studies demonstrate that participants in customized interventions experience greater reductions in body mass and improved health metrics. For instance, a community initiative revealed that 63.4% of participants achieved at least a 3% reduction in body mass within six months, highlighting the effectiveness of tailored strategies.

Case studies from our clinic reveal transformative results. One patient, who participated in our program utilizing non prescription weight loss injections for reducing body mass, reported a decrease of 21 lbs over a six-month period, along with significant enhancements in energy levels and overall health. This aligns with findings from broader studies indicating that non prescription weight loss injections can enhance satiety and regulate cravings, which facilitates adherence to healthier eating plans.

Expert opinions in the Lafayette healthcare community emphasize the importance of addressing obesity through personalized interventions, particularly for individuals with specific health challenges. By concentrating on customized solutions, Innovative Medicine distinguishes itself as a leader in offering effective management strategies that prioritize both physical and mental well-being. When you choose us, you’re not just getting a treatment; you’re gaining a partner in your health journey.

Saxenda: A Leading Non-Prescription Weight Loss Injection

For many, managing weight can feel overwhelming, especially with the uncertainty surrounding effective treatments like Saxenda. Saxenda (liraglutide) is a daily injectable medication that mimics the hormone GLP-1, which plays a crucial role in appetite regulation. Many people have found that using Saxenda can lead to meaningful weight loss, especially when combined with a healthy diet and regular exercise.

In a thorough study involving 3,731 participants, those treated with Saxenda experienced an average reduction of 21 pounds, with 27.9% achieving at least a 5% decrease in body mass. Furthermore, the average baseline body mass of participants was 233.9 pounds, emphasizing the potential for significant health enhancements. As the market evolves, with Novo Nordisk planning to discontinue Saxenda by late January 2027, the uncertainty of losing a trusted treatment option can be daunting for many. Individuals are encouraged to consult healthcare providers for alternative treatments, ensuring they remain informed about their options for effective weight management. Staying informed and proactive can empower you to navigate your weight management journey with confidence and support.

At Innovative Medicine, we pride ourselves on our compassionate and innovative approach to personalized healthcare. Our individuals have shared their experiences, highlighting the attentive care they receive.

• One individual expressed gratitude for the excellent care from Dr. Turner and his staff, noting how they listened to their concerns and adjusted treatment plans accordingly.
• Another patient shared their excitement about the supportive environment at Innovative Medicine, stating, "I am so grateful for the excellent care I receive from Dr. Turner and his staff!"

These heartfelt stories reflect our commitment to providing personalized care that truly meets the unique needs of each individual, including fat reduction, hormone therapy, pain management, and more.

Wegovy: An Effective Non-Prescription Weight Loss Injection

Many people struggle with the emotional and physical toll of obesity, feeling overwhelmed and unsure of where to turn for help. Wegovy (semaglutide) is a once-weekly injection that can provide significant support for adults seeking non-prescription weight loss injections to address these challenges. By mimicking the GLP-1 hormone, Wegovy effectively reduces appetite and enhances feelings of fullness. Clinical studies show that patients can achieve an average loss of about 15% over a 68-week period, with many experiencing even greater results. With 89% of participants using Wegovy HD seeing a reduction in body mass compared to only 38% on placebo, it’s clear that Wegovy can be a reliable partner in your journey toward a healthier weight.

With its convenient dosing schedule and proven effectiveness, Wegovy stands out as a compelling option for those in Lafayette, Indiana, looking to manage their health effectively. At Innovative Medicine, we’re here to support you with personalized healthcare solutions that truly meet your needs, including programs designed for individual needs, hormone therapy, and pain management. Our caring team is dedicated to providing thorough support, ensuring that each patient receives the assistance they require on their journey to a healthier lifestyle. Patients have shared their positive experiences, highlighting the attentive staff and effective, compassionate care they received. Discover how non-prescription weight loss injections, such as Wegovy, can be the supportive ally you need on your path to a healthier lifestyle. For additional details about our services, including our three unique programs for losing pounds, visit us at 3554 Promenade Pkwy, Suite H, Lafayette, IN 47909, or call (765) 471-1100.

Plenity: A Unique Non-Prescription Injection for Weight Management

For many, the journey to a healthier weight can feel daunting, especially when faced with the daily struggle of portion control and cravings. Imagine feeling satisfied with smaller portions, as Plenity gently expands in your stomach, helping you manage your cravings and food intake.

In clinical trials, many participants found success, with an average weight loss of about 6.4% over six months, showing that Plenity can truly make a difference in your journey. For those in Lafayette, Indiana, where many struggle with weight management, Plenity offers a compassionate solution to the daily challenges of portion control.

Recommended for adults with a BMI of at least 25, Plenity stands out as a non-invasive option for those seeking to improve their health. With Plenity, individuals can find a supportive ally in their quest for a healthier lifestyle, transforming their relationship with food and their bodies.

Ecnoglutide: An Emerging Non-Prescription Weight Loss Injection

For many, the journey to achieving a healthier body can feel overwhelming and frustrating, especially when traditional methods fall short. Imagine feeling stuck in your journey to a healthier body, searching for solutions that truly work. Ecnoglutide is here to change that, showing remarkable promise in clinical trials for effective body mass reduction. Recent studies reveal that participants have achieved an impressive average reduction of 15.4% over a 48-week period.

For those seeking a reliable option, non-prescription weight loss injections such as Ecnoglutide offer hope and a fresh start on the path to wellness. With nearly 93% of participants in trials experiencing clinically significant reductions in body mass, Ecnoglutide stands out as a viable option for those in Lafayette, Indiana, eager to enhance their health and wellness journey.

At Innovative Medicine, we’re here to create a personalized treatment plan just for you, integrating Ecnoglutide into our comprehensive approach to body composition, hormone therapy, and pain management. Our caring team is committed to walking alongside you, offering the support you need every step of the way on your journey to better health. With Ecnoglutide, you’re not just choosing a treatment; you’re embracing a supportive path toward a healthier you.

Monlunabant: A Promising Non-Prescription Weight Loss Injection

Are you struggling to manage your body mass and feeling overwhelmed by the options available? Monlunabant is a new option for those looking to reduce body mass with non prescription weight loss injections. Clinical trials have shown that participants using Monlunabant experienced notable reductions in body mass compared to those on placebo, with some achieving decreases of up to 8.0 kg over a 16-week period. Specifically, those on a 10 mg daily dose lost an average of 7.1 kg, while the placebo group saw only a modest reduction of 0.7 kg. This groundbreaking treatment targets the endocannabinoid system, which plays a crucial role in appetite regulation. This positions Monlunabant as a potential game-changer for individuals in Lafayette, Indiana, seeking non prescription weight loss injections to effectively manage their health. The outcomes from these trials suggest that Monlunabant not only assists in reducing body mass but also shows promise in enhancing metabolic markers, making it a significant option for those pursuing holistic health solutions.

At Innovative Medicine, we’re here to support you with personalized holistic healthcare solutions, from body transformation programs to hormone therapy and pain management. Our compassionate team, led by Dr. Charles Turner, MD, is dedicated to providing effective care tailored to your needs. With Monlunabant, you can take a confident step towards achieving your health goals and feeling your best.

For more information or to schedule an appointment, please contact us at (765) 471-1100 or visit us at 3554 Promenade Pkwy, Suite H, Lafayette, IN 47909.

Retatrutide: A New Frontier in Non-Prescription Weight Loss Injections

Imagine struggling with weight loss, feeling like you’ve tried everything without success. Retatrutide offers a new hope. This investigational triple hormone receptor agonist has shown remarkable efficacy in clinical trials, with participants reporting an average reduction in body mass of up to 30% over 80 weeks. With its innovative approach, it stands out as a beacon of hope for those seeking effective solutions.

By targeting multiple pathways involved in appetite regulation and metabolism, Retatrutide presents a promising strategy for significant reductions in body mass using non prescription weight loss injections. Notably, over 45% of participants achieved a reduction in body mass exceeding 30%.

While it’s true that Retatrutide hasn’t received FDA approval yet, ongoing research is paving the way for its future availability. As we await further developments, the promise of Retatrutide shines brightly, offering hope for those seeking effective solutions.

CagriSema: A Combination Approach to Non-Prescription Weight Loss

For many, the journey to achieving a healthier body can feel overwhelming, especially when faced with the challenges of weight management. CagriSema, a blend of cagrilintide and semaglutide, offers a supportive solution aimed at improving outcomes for reducing body mass effectively. Clinical trials reveal that this innovative combination can lead to an impressive average reduction of 22.7% in adults without diabetes. By harnessing the unique strengths of both agents, CagriSema provides a powerful option for individuals looking to enhance their fat loss efforts with non prescription weight loss injections.

Some individuals may face challenges with treatment adherence due to side effects, but many find the benefits far outweigh these concerns. Significantly, 34.7% of participants achieved at least a 25% decrease in body mass, while 23.1% lost over 30%. Common gastrointestinal adverse events were primarily mild-to-moderate, including nausea, constipation, and vomiting. Dr. Timothy Garvey highlights that CagriSema shows remarkable effectiveness, offering hope for those struggling with weight management. This underscores its potential as a transformative treatment for those in Lafayette looking to improve their health and well-being.

With CagriSema, individuals in Lafayette have a promising option that could lead to lasting improvements in their health and quality of life.

Aleniglipron: A Research-Backed Non-Prescription Weight Loss Injection

Many individuals struggle with body composition despite their best efforts, seeking effective solutions that truly work. Aleniglipron is here to help. In recent clinical trials, this innovative oral medication has shown remarkable potential for reducing body mass, especially for those in Lafayette, Indiana, looking to improve their health. In a recent Phase 2b trial, participants experienced an average reduction in mass of up to 15% over 36 weeks, particularly those on the highest dose of 240 mg from the exploratory ACCESS II trial.

It works by helping your body release insulin and curbing your appetite, so you can manage your body composition without the hassle of injections. Notably, 86% of participants on the 120 mg dose achieved at least a 5% reduction in body mass, a key benchmark for effective obesity treatment according to FDA guidelines. Plus, with a favorable safety profile - no reports of drug-induced liver injury or QTc prolongation - Aleniglipron stands out as a viable option for those aiming to enhance their health and well-being in the Lafayette area.

At Innovative Medicine, we believe in a holistic approach. Aleniglipron can be part of a personalized treatment plan that includes hormone therapy and nutritional counseling, all designed to support your journey. As the landscape for obesity treatments evolves, choosing Aleniglipron could be the turning point in your health journey, offering a reliable path to achieving your goals.

Survodutide: A Novel Non-Prescription Weight Loss Injection

For many, the struggle with weight can feel overwhelming, but there’s hope on the horizon. Survodutide represents a promising new option for those looking to manage their weight effectively and safely. In fact, participants in clinical trials experienced an impressive average weight loss of 16.6% over 76 weeks, compared to just 3.2% for those on a placebo. Not only does Survodutide help with weight loss, but it also supports better metabolic health, making it an appealing choice for those in Lafayette seeking non prescription weight loss injections. Remarkably, 85.1% of those using Survodutide saw at least a 5% reduction in their body mass, showcasing its promise for those battling obesity and related health issues.

At Innovative Medicine, we’re dedicated to walking alongside you, providing the compassionate support you need on your weight loss journey. With the right support and innovative treatments, a healthier future is within reach.

Conclusion

Many individuals find weight management overwhelming and confusing, often feeling lost in a sea of options. At Innovative Medicine, we understand that personalized care can significantly enhance outcomes. Our tailored non-prescription weight loss injections cater to individual health needs, ensuring that each patient receives the support necessary to achieve their weight loss goals. This commitment to personalized care not only addresses the physical aspects of weight loss but also fosters a holistic approach to overall well-being.

Throughout this article, we've explored various non-prescription weight loss injections, including:

1. Saxenda
2. Wegovy
3. Plenity
4. Ecnoglutide
5. Monlunabant
6. Retatrutide
7. CagriSema
8. Aleniglipron
9. Survodutide

Each option presents unique benefits and effectiveness, supported by clinical studies and patient testimonials that highlight their potential for significant weight loss and improved health metrics. The compassionate care provided by the team at Innovative Medicine, led by Dr. Charles Turner, MD, ensures that patients feel supported and understood throughout their journey.

As the landscape of weight management continues to evolve, considering personalized weight loss injections and engaging with a dedicated healthcare team can empower individuals to take control of their health. For those in Lafayette, Indiana, seeking effective weight management solutions, reaching out to Innovative Medicine at (765) 471-1100 or visiting their clinic at 3554 Promenade Pkwy, Suite H, can be the first step toward achieving lasting health and wellness. Taking that first step can lead to a healthier, more fulfilling life, one where you feel empowered and supported every step of the way.

Frequently Asked Questions

What is the focus of Innovative Medicine's weight loss programs?

Innovative Medicine focuses on individualized care, integrating natural and conventional medical methods to create personalized treatment plans that include non-prescription weight loss injections tailored to meet unique health objectives.

How effective are personalized weight loss programs according to recent statistics?

Personalized weight loss programs can significantly enhance results, with studies showing that participants in customized interventions experience greater reductions in body mass and improved health metrics. For example, a community initiative found that 63.4% of participants achieved at least a 3% reduction in body mass within six months.

Can you provide an example of success from Innovative Medicine's weight loss program?

One patient reported a decrease of 21 lbs over six months while using non-prescription weight loss injections, along with significant improvements in energy levels and overall health.

What is Saxenda and how does it work for weight loss?

Saxenda (liraglutide) is a daily injectable medication that mimics the hormone GLP-1, which regulates appetite. It has been shown to lead to meaningful weight loss, especially when combined with a healthy diet and regular exercise.

What were the results of the study involving Saxenda?

In a study with 3,731 participants, those treated with Saxenda experienced an average reduction of 21 pounds, with 27.9% achieving at least a 5% decrease in body mass.

What is the future of Saxenda as a treatment option?

Saxenda is planned to be discontinued by Novo Nordisk by late January 2027, prompting individuals to consult healthcare providers for alternative treatments for effective weight management.

What is Wegovy and how does it assist with weight loss?

Wegovy (semaglutide) is a once-weekly injection that mimics the GLP-1 hormone, effectively reducing appetite and enhancing feelings of fullness, leading to significant weight loss.

What are the clinical study results for Wegovy?

Clinical studies show that patients using Wegovy can achieve an average loss of about 15% over a 68-week period, with 89% of participants seeing a reduction in body mass compared to only 38% on placebo.

How does Innovative Medicine support patients in their weight loss journey?

Innovative Medicine provides personalized healthcare solutions, including programs for individual needs, hormone therapy, and pain management, with a dedicated team offering thorough support and compassionate care.

Where can individuals learn more about Innovative Medicine's services?

Individuals can visit Innovative Medicine at 3554 Promenade Pkwy, Suite H, Lafayette, IN 47909, or call (765) 471-1100 for additional details about their services and weight loss programs.

List of Sources

1. Innovative Medicine: Personalized Weight Loss Injections for Holistic Health
   • Weight Loss Injections Lafayette LA | GLP-1 Injections Lafayette LA (https://myminutemed.com/weight-loss-injections)
   • An Evaluation of a Personalized Multicomponent Commercial Digital Weight Management Program: Single-Arm Behavioral Trial - PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC10498321)
   • Personalized predictions to identify individuals most likely to achieve 10% weight loss with a lifestyle intervention (https://onlinelibrary.wiley.com/doi/10.1002/oby.24258)
   • Structured Program for Weight Loss in Heart Failure Patients: Findings From a Cardiology-Driven Obesity Clinic - PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC11198054)
   • HelloNation Highlights the Benefits of Medically Supervised Weight Loss Featuring Wellness Expert Dr. Charles Turner (https://prnewswire.com/news-releases/hellonation-highlights-the-benefits-of-medically-supervised-weight-loss-featuring-wellness-expert-dr-charles-turner-302697271.html)
2. Saxenda: A Leading Non-Prescription Weight Loss Injection
   • Prescription Weight-Loss Medicine | Saxenda® (liraglutide) injection 3mg (https://saxenda.com)
   • Why 2026 Will Reshape Access to GLP-1 Weight Loss Drugs | Newswise (https://newswise.com/articles/why-2026-will-reshape-access-to-glp-1-weight-loss-drugs)
   • FDA Approves First Generic GLP-1 Liraglutide for Weight Loss | Drug Topics (https://drugtopics.com/view/fda-approves-first-generic-glp-1-liraglutide-for-weight-loss)
   • Saxenda® (liraglutide) Injection 3 mg Clinical Trials for Weight Loss Results (https://novomedlink.com/obesity/products/treatments/saxenda/efficacy-safety/significant-weight-loss.html)
3. Wegovy: An Effective Non-Prescription Weight Loss Injection
   • Wegovy weight loss pill gets UK approval (https://bmj.com/content/393/bmj-2026-059332)
   • FDA Approves Novo Nordisk’s New Wegovy HD Injection, Delivering the Highest Weight Loss to Date for a Wegovy Injection (https://drugs.com/newdrugs/fda-approves-novo-nordisk-s-new-wegovy-hd-delivering-highest-weight-loss-date-wegovy-6749.html)
   • Wegovy® Pen Results and Weight Loss Data | Wegovy® (semaglutide) (https://wegovy.com/obesity/is-wegovy-right-for-me/wegovy-pen-results.html)
   • Wegovy obesity pill now available at pharmacies (https://npr.org/sections/shots-health-news/2026/01/05/nx-s1-5667020/wegovy-pill-obesity-weight-loss)
4. Plenity: A Unique Non-Prescription Injection for Weight Management
   • Plenity (Oral Superabsorbent Hydrogel) - PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC7364464)
   • New Weight Loss Treatment Is Marked by Heavy Marketing and Modest Results - KFF Health News (https://kffhealthnews.org/insurance/new-weight-loss-treatment-is-marked-by-heavy-marketing-and-modest-results)
   • The FDA Just Approved a New Prescription Weight-Management Device. Here's How It Works (https://time.com/5570718/plenity-weight-loss-drug)
   • Plenity – A New Approach to Weight Loss – touchENDOCRINOLOGY (https://touchendocrinology.com/insight/plenity-a-new-approach-to-weight-loss)
5. Ecnoglutide: An Emerging Non-Prescription Weight Loss Injection
   • Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide (https://prnewswire.com/news-releases/head-to-head-study-validates-the-clinical-advantage-of-new-generation-biased-glp-1-ecnoglutide-delivers-35-greater-weight-loss-than-semaglutide-302793395.html)
   • Ecnoglutide Shows Greater Weight Loss Than Semaglutide in Trial (https://clinicaltrialvanguard.com/news/ecnoglutide-shows-greater-weight-loss-than-semaglutide-in-trial)
   • Pfizer Builds Global GLP-1 Strategy With up to $495M Sciwind Deal (https://biospace.com/deals/pfizer-builds-global-glp-1-strategy-with-up-to-495m-sciwind-deal)
   • Ecnoglutide Delivers 35% Greater Weight Loss Than Semaglutide in Head-to-Head Trial | HCPLive (https://hcplive.com/view/ecnoglutide-delivers-35-greater-weight-loss-than-semaglutide-in-head-to-head-trial)
6. Monlunabant: A Promising Non-Prescription Weight Loss Injection
   • Novo Nordisk's Monlunabant Shows Weight Loss Potential in Phase 2a Obesity Trial (https://trial.medpath.com/news/novo-s-next-gen-cb1-drug-leads-to-weight-loss-in-phase-ii-but-neuropsychiatric-events-reported)
   • Questions over Novo Nordisk $1bn weight loss drug after Phase IIa trial (https://clinicaltrialsarena.com/news/novo-nordisk-weight-loss-drug-questions-remain)
   • Monlunabant induces clinically meaningful weight loss, raises questions over tolerability (https://springermedicine.com/obesity/drug-therapy-in-internal-medicine/monlunabant-induces-meaningful-weight-loss-tolerability/51567886)
   • Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players (https://finance.yahoo.com/news/novo-nordisks-monlunabant-data-drags-191843281.html)
7. Retatrutide: A New Frontier in Non-Prescription Weight Loss Injections
   • Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial (https://prnewswire.com/news-releases/lillys-triple-agonist-retatrutide-delivered-powerful-weight-loss-in-pivotal-phase-3-obesity-trial-302778859.html)
   • Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery (https://uchealth.org/today/retatrutide-for-weight-loss)
   • Phase III retatrutide study demonstrates 30% weight loss (https://pharmaceutical-journal.com/article/news/phase-iii-retatrutide-study-demonstrates-30-weight-loss)
   • Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial | Eli Lilly and Company (https://investor.lilly.com/news-releases/news-release-details/lillys-triple-agonist-retatrutide-delivered-powerful-weight-loss)
8. CagriSema: A Combination Approach to Non-Prescription Weight Loss
   • Novo Nordisk’s CagriSema Falls Short of 25% Weight Loss Target in Patients with Obesity or Overweight | PharmExec (https://pharmexec.com/view/novo-nordisk-cagrisema-falls-short-25-weight-loss-target-patients-obesity-overweight)
   • CagriSema Demonstrates Significant Weight Loss in Adults with Obesity | American Diabetes Association (https://diabetes.org/newsroom/press-releases/cagrisema-demonstrates-significant-weight-loss-adults-obesity)
   • CagriSema Demonstrates Weight Loss, Fails to Achieve Primary Endpoint Compared to Tirzepatide | HCPLive (https://hcplive.com/view/cagrisema-demonstrates-weight-loss-fails-to-achieve-primary-endpoint-compared-to-tirzepatide)
   • Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026 (https://prnewswire.com/news-releases/novo-nordisks-cagrisema-2-4-mg--2-4-mg-demonstrated-significant-reduction-in-hba1c-and-weight-across-multiple-studies-in-the-reimagine-program-presented-at-ada-2026--302793443.html)
9. Aleniglipron: A Research-Backed Non-Prescription Weight Loss Injection
   • Structure’s GLP-1 pill shows ‘best-in-class’ potential in obesity trial (https://biopharmadive.com/news/structure-glp1-pill-aleniglipron-study-results-obesity/814786)
   • Structure Therapeutics announces positive results from aleniglipron trial (https://clinicaltrialsarena.com/news/structure-therapeutics-aleniglipron-trial)
   • Aleniglipron’s Phase 2b Data Redraws the Oral GLP-1 Efficacy Map — And Raises Hard Questions for Phase 3 Design (https://clinicaltrialvanguard.com/article/intel-brief/alenigliprons-phase-2b-data-redraws-the-oral-glp-1-efficacy-map-and-raises-hard-questions-for-phase-3-design)
   • Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial - Nature Medicine (https://nature.com/articles/s41591-026-04476-6)
   • Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron | Structure Therapeutics (https://ir.structuretx.com/news-releases/news-release-details/structure-therapeutics-reports-positive-topline-data-access)
10. Survodutide: A Novel Non-Prescription Weight Loss Injection

• Boehringer dual-acting obesity shot hits mark in Phase 3 trial (https://biopharmadive.com/news/survodutide-obesity-drug-results-boehringer-ingelheim-zealand/818664)
• Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D | HCPLive (https://hcplive.com/view/survodutide-shows-fat-mass-loss-liver-fat-reductions-patients-obesity-without-t2d)
• New study: survodutide produces 16.6% weight loss in Phase 3 trial (https://secondnature.io/guides/blog/current-health/survodutide-weight-loss-phase-3?srsltid=AfmBOop9DjLV1a_5RJ2u2HAELB1yv3WK9de7zApbqMujV6XT12JN3gXN)
• New data may cast doubt on competitiveness of Boehringer’s obesity drug (https://statnews.com/2026/06/07/boehringer-ingelheim-obesity-drug-survodutide-phase-3-data)
• Survodutide Shows Positive Results for Achieving Weight Loss While Improving Metabolic Dysfunction | Docwire News (https://docwirenews.com/post/survodutide-shows-positive-results-for-achieving-weight-loss-while-improving-metabolic-dysfunction)